Metachronous Acquired Contralateral Cryptorchidism in Patients With a History of Unilateral Cryptorchidism.
Estimation of the Risk of Presenting Metachronous Acquired Contralateral Cryptorchidism in Patients With a History of Unilateral Cryptorchidism.
1 other identifier
observational
126
1 country
1
Brief Summary
The present study aims to calculate the risk of a patient with a history of cryptorchidism developing cryptorchidism on the contralateral side.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2024
CompletedFirst Submitted
Initial submission to the registry
July 25, 2024
CompletedFirst Posted
Study publicly available on registry
August 1, 2024
CompletedAugust 1, 2024
July 1, 2024
2 months
July 25, 2024
July 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Contralateral Cryptorchidism
Proportion of patients previously operated on for cryptorchidism in whom acquired contralateral cryptorchidism is detected.
Up to 1 month
Interventions
Patients previously operated on for cryptorchidism.
Eligibility Criteria
Patients previously operated on for cryptorchidism
You may qualify if:
- Patients aged 13 years or older, previously operated on for cryptorchidism.
You may not qualify if:
- Diagnosis of endocrine disease or any polymalformative syndrome.
- Synchronous bilateral cryptorchidism.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Consorci Sanitari Alt Penedès-Garraf
Vilafranca del Penedès, Barcelona, 08720, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carme Grande Moreillo, MD
CSAPG
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 25, 2024
First Posted
August 1, 2024
Study Start
April 1, 2024
Primary Completion
May 30, 2024
Study Completion
May 30, 2024
Last Updated
August 1, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- After publication of main results of the study.
- Access Criteria
- IPD will be shared only for scientific research purposes and following the Spanish and European Union normative law about data protection. The requirements will be directed to the IP of the study. The IP will evaluate the request to verify and evaluate the data that is requested and the purposes for which it is requested. Next, the IP will transfer the request to the promotor center the study for the final decision.
IPD (without personal identification data) could be shared by requirement from other researchers after the end of the study, and only for research purposes and previous approval of promotor center of the study (CSAPG). Anyway, Spanish and European Union legal policy about data protection will strictly be followed (IPD will not be transferred outside European Union).